IHS Chemical Week

Regions :: North America :: U.S.

Merck & Co. Sells U.S. Pharma Plant to Market Entrant

10:33 AM MST | January 14, 2008 | Alex Scott

Merck & Co. says it has sold a pharmaceuticals manufacturing facility at Riverside, PA to manufacturing services firm PRWT Services (Philadelphia). The Riverside plant manufactures antibiotics for humans and animals. PRWT will supply product from the facility at Riverside to Merck & Co. for the next five years under terms of the agreement. PRWT estimates the supply deal to be worth $100 million-$200 million in total. Acquiring the Riverside plant marks PRWT’s entry into the pharma manufacturing sector. PRWT has established a subsidiary...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa